. Pedigrees of the 12 Chinese families included in this study and segregation analysis of the biallelic mutations of the BEST1 gene. Squares represent men, and circles represent women. Solid symbols indicate patients affected with bestrophinopathy. Unfilled symbols represent unaffected family members. A diagonal line indicates a deceased family member. The arrow indicates the proband. deposits and an accumulation of fluid within and/or beneath the neurosensory retina in the macula without vitelliform lesions typical of BVMD. In contrast to most BVMD cases, full-field electroretinography (ERG) shows reduced and delayed rod and cone responses and severe reduction or absence of the EOG light rise. ARB has been found in association with either homozygous or compound heterozygous BEST1 mutations [16] .
To date, most genetic and phenotypic studies of bestrophinopathy have been performed in Western populations, and only limited data are available for Chinese patients [17] [18] [19] . The aim of the present study was to screen for BEST1 gene mutations in Chinese patients affected by bestrophinopathy and to describe their clinical features. Clinical studies: Thirteen patients diagnosed with bestrophinopathy from 12 independent pedigrees were recruited from the Department of Ophthalmology, Peking Union Medical College Hospital (Figure 1 ). Detailed ophthalmic examinations were conducted on all subjects, including best-corrected visual acuity (BCVA), slit-lamp biomicroscopy, fundus examination and photography, optical coherence tomography (OCT), fundus autofluorescence (FAF), EOG, and ERG. The fundus images and OCT images were in most cases taken with Topcon-3D OCT-1000 (Topcon Medical Systems, Tokyo, Japan), and FAF examinations were performed with the Spectralis HRA-OCT produced by Heidelberg Engineering (Heidelberg, Germany). EOG and ERG (RetiPort ERG system; Roland Consult, Wiesbaden, Germany) were performed according to the International Society for Clinical Electrophysiology of Vision (ISCEV) standards [20, 21] .
METHODS

Molecular genetic studies:
Peripheral blood samples were obtained from all subjects, and genomic DNA was extracted by using a QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany). All exons and the flanking introns of the BEST1 gene were amplified with PCR using previously reported primers [22] a BEST1 reference sequence (GeneBank accession number NM_004183). One hundred control chromosomes from the same ethnic background were also screened to exclude nonpathogenic polymorphisms.
RESULTS
Clinical evaluation:
All patients from families A-F had the typical fundus appearance of BVMD, ranging from vitelliform lesion to pseudohypopyon change. Typical Arden ratios of EOG less than the cutoff value of 1.5 were observed. Age at onset of the disease varied widely in these patients (mean age ± standard deviation [SD] 25.9±16.6 years), as was visual acuity. BCVA ranged from 20/100 to 20/32. Detailed clinical data of these patients are summarized in Table 1 . Fundus photographs, OCT, and FAF images of selected patients are shown in Figure 2 .
In the other four patients from families I-L, typical vitelliform lesions of BVMD at different stages were also observed ( Figure 3 ). For patient II:2 (family K), the EOG showed a decreased Arden ratio (OD 1.20; OS 1.32), while the ERG revealed normal cone and rod responses. The mean age at disease onset of these patients was 12.5 (SD 6.6) years, and BCVA varied widely, ranging from 20/400 to 20/32 ( Table  1) . Comparison of clinical data between these patients and patients from families A-F revealed no significant differences in age at onset or visual acuity (p>0.05), although age at onset seemed to be younger in these patients. No family history of Best disease was observed in these families. Figure 5 ). The amplitudes of the scotopic and photopic full-field ERG responses were decreased. The Arden ratio of EOG was 1.11 OD and 1.23 OS. Based on these findings, the two patients were clinically diagnosed with ARB. Their parents showed no clinical signs of the disease.
Genetic evaluation: Seven patients from families A-F harbored one heterozygous BEST1 mutation. Based on this Figure 6 . Multiple sequenced alignment of bestrophin-1 around the mutated residues for eight species. The amino acids boxed with colors indicate the positions of novel mutations in the present study. Mutations in a heterozygous state were marked with blue, while mutations in a homozygous or compound heterozygous state were marked with orange. These mutations occurred in highly conserved regions.
finding, along with the typical fundus appearance of BVMD in these patients and the positive family history, an AD inheritance pattern of BVMD was established in these families. Five missense mutations were identified, including two novel mutations (p.T4I and p.A291V) and three reported mutations (p.R218C, p.Q293H, and p.D301G; Table 2 ). The novel mutations occurred in highly conserved regions ( Figure 6 ).
Six patients from families G-L carried biallelic mutations in the BEST1 gene. Segregation analysis of the disease in these families along with the negative family history revealed an AR inheritance mode. Compound heterozygous mutations (p.R13H, p.Y33H, p.A195V, p.R255W, p.W287*, and c.519delA) were identified in four patients with BVMD from families I-L, and homozygous mutations (p.M163R and p.R130L) were found in two patients with ARB from families G-H ( Table 2 ). The p.A195V and p.R255W mutations were observed in two patients. To the best of our knowledge, mutations p.Y33H, c.519delA, p.R130L, and p.M163R had not been reported previously, and none were observed in any of the 100 ethnically matched control chromosomes or present in the Single Nucleotide Polymorphism database (SNP) or in the 1000 Genomes Project data set. All the novel mutations occurred in highly conserved regions among different species ( Figure 6 ). Figure 7 . Diagrams of human bestrophin-1 summarizing known BEST1 mutations associated with BVMD and ARB phenotypes [10] . A: Protein model of bestrophin-1 proposed by Tsunenari et al. [33] ; B: Protein model of bestrophin-1 proposed by Milenkovic et al. [34] . Colored residues indicate a missense mutation or in-frame deletion, while the colored bar indicates a nonsense or frameshift mutation. Mutations in the homozygous or compound heterozygous state reported in the present study are marked with *.
DISCUSSION
In this study, we assessed the phenotypes and genotypes of 13 patients from 12 unrelated Chinese families affected by bestrophinopathy. Mutation analysis revealed biallelic BEST1 mutations in six patients, indicating that patients carrying biallelic BEST1 mutations are common among Chinese bestrophinopathy patients. The detection rate of BEST1 mutations was high, which confirmed the strong association between bestrophinopathy and BEST1 sequence variants. Overall, six novel BEST1 mutations were identified. The high prevalence of novel mutations suggests a difference in the spectrum of BEST1 mutations between Chinese patients and other ethnic groups.
Genes that could cause the same disease in different inheritance modes are not rare. For instance, different mutations in the RHO and RP1 genes can cause adRP or arRP based on their pathogenic effects [13] . In the majority of cases, BVMD is inherited as an AD trait caused by heterozygous mutations in the BEST1 gene, yet AR Best disease has been reported in several families [12] [13] [14] [15] . In the present study, families A-F were affected by typical BVMD in an AD inheritance fashion, while families I-L were affected by BVMD in an AR inheritance pattern with segregation of biallelic BEST1 mutations. Clinical data showed no significant differences in onset age or visual acuity between the two groups, although age at onset seemed to be younger in patients with an AR inheritance mode. Our findings are consistent with previous reports and confirm that BEST1 could also cause AR Best disease [12] [13] [14] [15] .
Patients from family G-H who also carried biallelic BEST1 mutations demonstrated distinct clinical features from those of patients from family I-L. They were diagnosed with ARB based on their unique fundus appearance, reduced rod and cone responses of full-field ERG, and reduced Arden ratios of EOG [16] . Thus, biallelic BEST1 mutations could be associated with at least two phenotypes, BVMD and ARB, which is consistent with other reports of the association of biallelic BEST1 mutations with different clinical pictures, ranging from typical BVMD to ARB [14, 23, 24] .
Mutation analysis revealed five missense mutations in families A-F affected by typical AD Best disease, including two novel mutations (p.T4I and p.A291V) and three reported mutations (p.R218C, p.Q293H, and p.D301G). Exon 8 (amino acid 289-315) harbors 3/5 mutations and has been reported to have a disproportionately higher number of AD Best disease mutations compared with the other coding exons of the gene [25] . Exon 8 encodes for the C-terminal region of bestrophin-1, which interacts with protein phosphatase 2A [26] .
The conserved amino acid residues altered by mutations may play a critical functional role in this regulatory interaction.
Six compound heterozygous BEST1 mutations were identified in families I-L with AR Best disease, including p.R13H, p.Y33H, p.A195V, p.R255W, p.W287*, and c.519delA. They are all located outside the four clusters of hot spots defined for AD Best disease (6-30, 80-104, 221-243, and 293-312 amino acid regions) except mutation p.R13H [11] , indicating these mutations differ from those that cause typical AD Best disease in mutation locations; thus, a different pathologic mechanism is likely. Interestingly, mutations p.A195V and p.R255W were observed in two patients. Based on our study and a review of the literature [14, [27] [28] [29] [30] [31] , p.A195V is one of the most common mutations identified among patients who carry biallelic mutations. It has been frequently reported in patients with recessive bestrophinopathy in a compound heterozygous state with other mutations, including p.W93P, p.L134V, p.R141H, p.H490del2CTTCA, p.L88del17, and p.Q238L [14, [27] [28] [29] [30] [31] . The recurrence of p.A195V suggests that certain mutations have a higher predisposition to be pathogenic when present with other mutations on both alleles.
Mutations p.Y33H and c.519delA were novel mutations that had not been previously reported. They occurred in highly conserved regions of bestrophin across multiple species in which alterations may lead to structural or functional changes in the protein. Mutation p.Y33H is predicted to be functionally highly deleterious by the bioinformatic program PolyPhen-2 (score=1.00). Mutation c.519delA is a single base pair deletion that could cause a frame-shift effect and give rise to a premature stop after three nucleotides. This may result in nonsense-mediated decay of the mutant transcript and loss of the protein, leading to the disease.
The other four mutations p.R13H, p.A195V, p.R255W, and p.W287* have already been described in the literature. Mutation p.R13H and p.R255W were reported previously only in patients with BVMD [17, 32] . p.W287* was reported in only one patient with atypical Best disease in a compound heterozygous state with L191P, although the description of the phenotype suggested ARB [27] . Mutation p.A195V was reported in patients with BVMD and in patients with ARB carrying another BEST1 mutation on the other allele [14, [27] [28] [29] [30] [31] . The great clinical variability within our patients along with these data adds to the complexity of phenotypes associated with biallelic BEST1mutations. Due to epistatic effects, any allele can have a different level of gene transcription; thus, in patients who carry biallelic BEST1 mutations, the phenotypic variability could be related to epistatic effects and the interaction of pathogenic effects of different mutations.
Screening for the BEST1 gene revealed two homozygous mutations, p.M163R and p.R130L, respectively, in family G and H affected by ARB. Both were novel mutations in highly conserved regions of bestrophin across multiple species and predicted to be functionally highly deleterious by PolyPhen-2 (score=1.00; 0.99, respectively). Two topology models of human bestrophin-1 were proposed by Tsunenari et al. and Milenkovic et al. [33, 34] . The major difference is that Tsunenari et al.'s model shows bestrophin-1 has five transmembrane (TM) domains while the protein is predicted to have four TM domains in the model constructed by Milenkovic et al. However, in both models, homozygous mutations p.R130L and p.M163R associated with the ARB phenotype are located in the non-TM domains of the protein (Figure 7) . Twelve of 16 mutations related to ARB are located in the non-TM domains of bestrophin-1 in the two models ( Figure 7 ). This suggests that mutations with non-TM locations are more likely to be associated with the ARB phenotype than mutations residing in TM domains.
To conclude, we identified six novel and seven previously reported BEST1 mutations in a series of Chinese patients with bestrophinopathy, and described in detail the phenotypes of patients with ARB. To the best of our knowledge, this is the largest study in the literature investigating BEST1 mutations in a Chinese population. This is also the first systematic report of Chinese patients carrying biallelic mutations in the BEST1 gene.
